Sponsor or institution
Clinical trials and research at VeonGen Therapeutics GmbH
As of November 12, 2026, Find a Trial lists 2 clinical trials run by VeonGen Therapeutics GmbH that are recruiting, at sites in 2 countries (most in China (1), Germany (1)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
VG801 gene therapy for Stargardt disease from ABCA4 mutations
This open-label, first-in-human trial will try a single dose of VG801 gene therapy in people aged 6 and older who have Stargardt disease from two ABCA4 mutations to see if it is safe and helps vision.
-
Gene therapy for Retinitis Pigmentosa caused by CNGA1 mutations
This study is testing a new gene therapy called VG901 to see if it is safe and can help people with Retinitis Pigmentosa caused by CNGA1 gene mutations.
Quick answers
How many clinical trials run by VeonGen Therapeutics GmbH are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.